| Autor: |
MIKE GRADY, HILARY CAMERON, ELIZABETH H. HOLT |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Diabetes. 71 |
| ISSN: |
0012-1797 |
| Popis: |
Background: The OneTouch Verio Flex® (OTVF) meter with a 3-Color Range Indicator instantly sends readings by Bluetooth® to the OneTouch Reveal® (OTR) app. We sought to provide evidence that these products support improved glycemic control. Methods: Anonymous glucose and app analytics were extracted from the LifeScan server for 100650 people with type 2 diabetes (T2D) and 20324 people with type 1 diabetes (T1D) . Data from their first 14 days was compared to 14 days prior to a 90 day timepoint using paired within-subject differences. Results: Percentage glucose readings in-range (70-180mg/dl) improved by 8.7% (from 69.9 to 78.5%) in T2Ds and by 4.0% (from 56.1 to 60.1%) in T1Ds. Hyperglycemic readings (>180mg/dl) reduced by -8.8% (from 28.4 to 19.7%) in T2Ds and by -4.3% (from 38.4 to 34.0%) in T1Ds. Mean glucose reduced on average by -14.1mg/dl (from 160.6 to 146.5mg/dl) in T2Ds and by -6.7mg/dl (from 176.7 to 170.1mg/dl) in T1Ds. Just 4 to 10 sessions per week or 20 to 60 minutes per week on the OTR app improved readings in-range in T2Ds by 9% or 10%, respectively (see graphs below) . Similar trends were observed in people with T1D. Conclusion: Real world data from over 120000 people with diabetes demonstrates significantly improved data in-range and lower mean glucose in those using the OneTouch Verio Flex® meter and OneTouch Reveal® app. Disclosure M. Grady: Employee; LifeScan. H. Cameron: None. E. H. Holt: Employee; Intarcia Therapeutics, Inc., LifeScan. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
